Physician profile
Eric J Williams
NPI 1699718064
$774.48
in general payments reported to CMS, 2019-2025
20 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $363 · 2020: $86.41 · 2021: $14.33 · 2022: $59.96 · 2023: $13.63 · 2024: $238.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $239 · Education: $12.15.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $239.02 |
| Education | $12.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $173.22 | 2024 | Caplyta |
| Indivior INC. | $86.01 | 2019-2024 | Sublocade |
| Merck Sharp & Dohme LLC | $81.97 | 2019-2022 | |
| Astrazeneca Pharmaceuticals LP | $76.46 | 2019-2022 | |
| Janssen Pharmaceuticals, INC | $58.20 | 2019-2020 | |
| Pacira Pharmaceuticals Incorporated | $34.76 | 2024 | Exparel |
| Eisai INC. | $28.44 | 2019 | |
| Horizon Therapeutics Plc | $28.43 | 2021-2022 | |
| Novo Nordisk INC | $28.16 | 2020-2022 | |
| Pfizer INC. | $28.13 | 2019-2020 | |
| Gilead Sciences, INC. | $20.74 | 2019 | |
| Allergan, INC. | $18.16 | 2019 | |
| Abbvie INC. | $15.22 | 2024 | |
| Arbor Pharmaceuticals, INC. | $14.85 | 2019 | |
| Sanofi Pasteur INC. | $14.84 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $14.41 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $13.71 | 2019 | |
| Orexo US, INC. | $13.63 | 2023 | Zubsolv |
| Lilly USA, LLC | $13.00 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $12.14 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Williams listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.